Clinical trial
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety…
NCT00358553 · Baxter Healthcare Corporation, Industry · Completed
Key facts
| NCT number | NCT00358553 |
|---|---|
| Title | A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin |
| Lead sponsor | Baxter Healthcare Corporation, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Insulin |
| First posted | Aug 1, 2006 |
| Last update posted | Mar 13, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: